ABSTRACT: Using an acetylcholine-derivatized affinity column, we have purified human R4 2 neuronal nicotinic acetylcholine receptors (nAChRs) from a stably transfected HEK-293 cell line. Both the quantity and the quality of the purified receptor are suitable for applying biochemical methods to directly study the structure of the R4 2 nAChR. In this first study, the lipid-protein interface of purified and lipidreconstituted R4 2 nAChRs was directly examined using photoaffinity labeling with the hydrophobic probe 3-(trifluoromethyl)-3-(m- 222 and Phe 227 at the lipid-exposed face of the Torpedo R1M1 segment. In 2M1, [ 125 I]TID labeled 2-Cys 220 , which is homologous to R4-Cys 226 . We conclude from these studies that the R4 2 nAChR can be purified from stably transfected HEK-293 cells in sufficient quantity and purity for structural studies and that the lipid-protein interfaces of the neuronal R4 2 nAChR and the Torpedo nAChR display a high degree of structural homology.
Neuronal nicotinic acetylcholine receptors (nAChRs) 1 are members of the Cys-loop superfamily of ligand-gated ion channels that mediate the actions of the neurotransmitter acetylcholine (1, 2) . Neuronal nAChRs are widely distributed in the nervous system and play a role in many physiological functions including arousal, sleep, attention, memory, mood, emotion, pain perception, food intake, and cognition and are implicated in numerous pathophysiological conditions including epilepsy, schizophrenia, Alzheimer's and Parkinson's diseases, anxiety, and nicotine addiction (reviewed in refs 3-5) . To date twelve mammalian neuronal nAChR subunit genes have been cloned, nine neuronal R subunits (R2-R10), and three neuronal subunits (2) (3) (4) . On the basis of the three-dimensional structure of the Torpedo nAChR (6, 7) and the available structural information regarding neuronal nAChRs (reviewed in refs 8 and 9), the R4 2 neuronal nAChR is a pentameric membrane protein that is formed by the assembly of two R4 and three 2 subunits. Each nAChR subunit contains a large extracellular N-terminus and a bundle of four transmembrane R helices (M1-M4). The five M2 helices are arranged about a central axis orthogonal to the membrane forming the channel lumen, and the M1, M3, and M4 helices form an outer ring that shields M2 from the lipid bilayer.
Due to the abundance and purity of muscle-type nAChR in preparations from the electric organ of the Torpedo electric ray, it is the most studied and understood member of the Cys-loop superfamily of ligand-gated ion channels, and many of the structural/functional features of the Torpedo nAChR may be generalized to other members of the superfamily including neuronal nAChRs. This approach is largely justified by the high sequence identity/homology between Torpedo and neuronal nAChR subunits (e.g., Torpedo R1 and neuronal R4 subunits display 53% sequence identity). At the same time, expression of neuronal nAChR in heterologous expression systems, combined with site-directed mutagenesis and I]iodophenyl)diazirine; Tricine, N-[tris (hydroxymethyl) methyl]glycine; VDB, vesicle dialysis buffer; V8 protease, Staphylococcus aureus glutamyl endopeptidase. electrophysiological analysis, have associated particular amino acid residues with agonist binding, channel gating, ion conductance, and desensitization (2, 9, 10) . Nevertheless, direct structural information regarding neuronal nAChRs is currently lacking. This is in large part due to the low expression level of individual neuronal nAChRs, the high level of diversity among neuronal nAChR subunits in a given brain area, and the lack of subunit-specific ligands.
Purification of individual neuronal nAChRs is an important step in the effort to directly study the structure of neuronal nAChRs and to reveal the structural differences among neuronal nAChR subtypes. We report here a purification strategy that provides highly purified neuronal nAChR in a lipid environment and in a quantity that is suitable for direct structural studies (e.g., photoaffinity labeling, Fourier transform infrared spectroscopy (FTIR), etc.). Membrane preparations from HEK-293 cells stably transfected with human R4 2 nAChRs were detergent solubilized, and the receptors were purified on an acetylcholine-derivatized affinity column and reconstituted into lipid. To begin direct structural studies of the R4 2 nAChR, we chose to examine the structure of the lipid-protein interface of the receptor and to determine amino acid residues of R4 and 2 subunits that are in contact with membrane lipid. For this we employed the hydrophobic photoreactive probe 3-(trifluoromethyl)-3-(m-[
I] iodophenyl)diazirine ([ I]TID). In earlier studies, [
125 I]TID was used to define the lipid-protein interface of the Torpedo nAChR (11, 12) . [ 125 I]TID photoincorporated into the M4 and M1 segments of both the R4 and 2 subunits with ∼60% of the total subunit labeling localized in the M4 segment. The labeled amino acids within the R4M4/ 2M4 and R4M1/ 2M1 segments correspond to residues labeled in the Torpedo nAChR M4/M1 segments, consistent with the existence of a high degree of structural homology between the transmembrane domain of the neuronal R4 2 nAChR and the Torpedo nAChR at the lipid-protein interface.
EXPERIMENTAL PROCEDURES

Materials. [
125 I]TID (∼10 Ci/mmol) was obtained from Amersham Biosciences (Piscataway, NJ) and stored in ethanol/water (3:1) at -4°C.
H]nicotine; ∼70 Ci/mmol) was obtained from Perkin-Elmer Life Sciences, Inc. (Boston, MA) and stored in 95% ethanol at 4°C. Carbamylcholine chloride and bromoacetylcholine bromide were purchased from Sigma-Aldrich (St. Louis, MO), Staphylococcus aureus glutamyl endopeptidase (V8 protease) was from MP Biochemicals, trypsin (TPCK-treated) was from Worthington, o-phthalaldehyde (OPA) and trifluoroacetic acid (TFA) were from Pierce, sodium cholate and CHAPS were from USB Corp. (Cleveland, OH), AffiGel 10 was from Bio Rad, and protease inhibitor cocktail III and Genapol C-100 were from Calbiochem. Prestained low-range molecular weight standards were purchased from Life Technologies, Inc. Dulbecco's modified Eagle's medium/ Ham's F-12 50:50 mix (DMEM/Ham's F-12) was purchased from Mediatech, Inc. (Herndon, VA). Natural and synthetic lipids were from Avanti Polar Lipids, Inc. (Alabaster, AL).
Cell Culture and Membrane Preparation. HEK-293 cells stably transfected with human R4 2 nAChRs (HEK-hR4 2 hereafter) were obtained from Dr. Joseph H. Steinbach (Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO; 13). The cells were grown at 37°C in a humidified incubator at 5% CO 2 , in 140 mm tissue culture dishes, and were maintained in DMEM/Ham's F-12 (Mediatech, Inc.), supplemented with 10% fetal bovine serum, 100 units/mL penicillin G, 100 µg/ mL streptomycin, and 450 µg/mL Geneticin (G418) as a selection agent. The use of 140 mm dishes for culturing these adherent cells (HEK-hR4 2) was determined to be the most cost-effective method for large-scale production of receptor protein. However, we are currently exploring culturing HEKhR4 2 cells in spinner flasks (5-15 L) with the addition of glass microcarriers (Cytodex-3) to scale up receptor protein production. In most cases, 100 µM nicotine was added to the medium 24 h prior to harvesting to enhance the expression of R4 2 nAChRs (10). The cells were harvested by gentle scraping in 5 mL of growth medium in the presence of protease inhibitor cocktail III (Calbiochem, 0.2 µL/mL), pelleted by centrifugation (210g for 4 min), resuspended in a small volume of vesicle dialysis buffer (VDB; 100 mM NaCl, 0.1 mM EDTA, 0.02% NaN 3 , 10 mM MOPS, pH 7.5), and then pelleted by centrifugation. The final cell pellet was stored at -80°C.
For membrane preparation, HEK-hR4 2 cells were thawed and homogenized in VDB in the presence of protease inhibitor cocktail III (Calbiochem, 1 µL/mL) using a glass homogenizer. Membrane fractions were pelleted by centrifugation (39000g for 1 h), then the membrane pellets were resuspended in VDB (∼0.5 mL/140 mm dish), and the protein concentration was determined by Lowry protein assay (14) .
[ Solubilization, Purification, and Reconstitution. Human R4 2 nAChRs were affinity-purified on a bromoacetylcholine bromide-derivatized Affi-Gel 10 column (Biorad) originally developed for purification of the Torpedo nAChR from electric organ tissue (15, 16) but with some modifications. Briefly, the affinity column matrix was prepared by aminocoupling cystamine to Affi-Gel 10, reduction with dithiothreitol, and final modification with bromoacetylcholine bromide. HEK-hR4 2 membranes were solubilized by adding an equal volume of 2% CHAPS or 2% cholate in VDB (final concentration 2 mg/mL protein, 1% detergent, final volume 800 mL), stirred for 5 h at 4°C, and then centrifuged (91500g for 1 h) to pellet insoluble material. The solubilized material was dialyzed for 5 h against 1% cholate in VDB (solubilized material to dialysis buffer ratio 1:10). This dialysis step is a critical aspect of the purification strategy; in its absence nAChRs are not retained on the ACh-affinity column. The dialyzed solubilized material was then treated with diisopropyl fluorophosphates (0.1 mM) and slowly applied to the affinity column (0.3 mL/min, ∼24 h, at 4°C) and the column then washed extensively with a defined lipid solution (e.g., total lipid extract from porcine brain, or dioleoylphosphatidylcholine:dioleoylphosphatic acid:cholesterol ) 3:1:1, 0.2 mg/mL lipid) in 1% cholate in VDB (15 column volumes, >15 h). This extensive wash ensures complete exchange of endogenous lipids for the defined lipid mixture and removal of nonspecific protein (16, 17) . Receptors were eluted from the column using the defined lipid solution containing 10 mM carbamylcholine. Fractions of 2.5 mL were collected, and the protein concentration was determined (A 280 × 0.6; 15). Peak protein fractions were pooled and dialyzed against 2 L of VDB (4 d with buffer change once a day) to remove carbamylcholine and detergent, thereby reconstituting nAChRs into membrane vesicles containing a defined lipid mixture. The purified nAChRs were stored at -80°C.
[
125 I]TID Photolabeling. For analytical labelings, 50 µg of affinity-purified and lipid-reconstituted R4 2 nAChRs was incubated with ∼0.4 µM [ 125 I]TID (∼10 Ci/mmol, Amersham Biosciences) in the absence or presence of 400 µM carbamylcholine in 1 mL of VDB. For preparative labelings, 1 mg of affinity-purified and lipid-reconstituted R4 2 nAChRs in 4 mL of VDB was incubated with ∼8 µM [ 125 I]-TID. After 1 h of incubation at room temperature under reduced light conditions, the samples were irradiated with a 365 nm hand-held UV lamp (Spectroline EN-280L) for 7 min (analytical labeling) or 20 min (preparative labeling) at a distance of less than 1 cm and then pelleted by centrifugation (39000g for 1 h). Pellets were solubilized in electrophoresis sample buffer (12.5 mM Tris-HCl, 2% SDS, 8% sucrose, 1% glycerol, 0.01% bromophenol blue, pH 6.8), and the polypeptides were resolved by SDS-PAGE.
SDS-Polyacrylamide Gel Electrophoresis. SDS-PAGE was performed according to Laemmli (18) with the 1.0 mm thick separating gel comprised of 8% polyacrylamide/0.33% bisacrylamide. The gels were stained for 1 h with Coomassie Blue R-250 (0.25% (w/v) in 45% methanol, 10% acetic acid, 45% H 2 O) and destained (25% methanol, 10% acetic acid, 65% H 2 O) to visualize bands. The gels were then dried and exposed to Kodak X-OMAT LS film with an intensifying screen at -80°C (12-48 h of exposure). After autoradiography, bands that correspond to [ 125 I]TID-labeled R4 and 2 subunits were excised, soaked in overlay buffer (5% sucrose, 125 mM Tris-HCl, 0.1% SDS, pH 6.8) for 30 min, and transferred to the wells of a 15% acrylamide mapping gel (19) . Each gel slice was overlaid with 2 µg (analytical labeling) or 100 µg (preparative labeling) of V8 protease in overlay buffer. After electrophoresis, the gels were stained for 2 h with Coomassie Blue R-250, destained, and then either prepared for autoradiography (analytical labeling) or soaked in distilled water overnight (preparative labeling). The bands corresponding to labeled subunit proteolytic fragments (R4V8-8, R4V8-14, R4V8-16, 2V8-8, 2V8-13, and 2V8-21) were excised from preparative gels, and the labeled peptides were retrieved by passive diffusion into 25 mL of elution buffer (0.1 M NH 4 HCO 3 , 0.1% (w/v) SDS, 1% -mercaptoethanol, pH 7.8) for 4 d at room temperature with gentle mixing. Gel pieces were removed by filtration (Whatman no. 1 paper), and the peptides were concentrated using Centriprep-10 concentrators (10 kDa cutoff, Amicon, final volume <150 µL). Samples were then either directly purified using reversed-phase HPLC (R4V8-16, and 2V8-8) or acetone precipitated (>85% acetone at -20°C overnight) to remove excess SDS and then subjected to additional proteolytic digestion (R4V8-14, 2V8-13, and 2V8-21).
Proteolytic Digestions. For digestion with trypsin, acetoneprecipitated subunit fragments (R4V8-14, 2V8-13, and 2V8-21) were suspended in 60 µL of 0.1 M NH 4 HCO 3 , 0.1% SDS, pH 7.8, and then the SDS content was diluted by addition of 225 µL of 0.1 M NH 4 HCO 3 and 35 µL of Genapol C-100 (final concentrations 0.02% (w/v) SDS, 0.5% Genapol C-100, pH 7.8). Trypsin was added at a 200% (w/ w) enzyme to substrate ratio, and the digestion was allowed to proceed for 4 d at room temperature.
Tricine SDS-PAGE. The tryptic digestion products of [ 125 I]TID-labeled fragment 2V8-21 were resolved on a 1.0 mm thick small pore (16.5% T, 6% C) Tricine SDS-PAGE gel (12, 20) . After electrophoresis, Tricine gels were processed for autoradiography as described above for 8% gels. Tricine gel bands containing [ 125 I]TID-labeled peptide fragments 2T6K, 2T10K, and 2T12K were excised and processed for HPLC purification.
ReVersed-Phase HPLC Purification. All of the [ 125 I]TIDlabeled peptides were purified using reversed-phase HPLC prior to sequence analysis. HPLC was performed on a Shimadzu LC-10A binary HPLC system, using a Brownlee Aquapore C 4 column (100 × 2.1 mm). Solvent A was comprised of 0.08% TFA in water and solvent B 0.05% TFA in 60% acetonitrile/40% 2-propanol. A nonlinear elution gradient at 0.2 mL/min was employed (25-100% solvent B in 100 min, shown as a dotted line in the figures), and fractions were collected every 2.5 min (42 fractions/run). The elution of peptides was monitored by the absorbance at 210 nm, and the amount of 125 I associated with each fraction was determined by γ counting.
Sequence Analysis. Amino-terminal sequence analysis of nAChR subunits and some subunit fragments was performed on a Beckman Instruments (Porton) 20/20 automated protein sequencer using gas-phase cycles (Texas Tech Biotechnology Core Facility). Pooled HPLC fractions were dried by vacuum centrifugation, resuspended in 20 µL of 0.1% SDS, and immobilized on chemically modified glass fiber disks (Beckman Instruments). Peptides were subjected to at least 10 sequencing cycles.
Sequencing of purified [ 125 I]TID-labeled subunit fragments was performed on an Applied Biosystems PROCISE 492 protein sequencer configured to utilize 1/6 of each cycle of Edman degradation for amino acid identification/quantification and collect the other 5/6 for 125 I counting. HPLC fractions of interest were diluted 3-fold with 0.1% trifluoroacetic acid and loaded onto PVDF filters using Prosorb sample preparation cartridges (Applied Biosystems no. 401959). Before sequencing, filters were processed as recommended by the manufacturer. To determine the amount of the sequenced peptide, the picomoles of each amino acid in a detected sequence was quantified by the peak height and fit to the equation f(x) ) I 0 R x , where I 0 is the initial amount of the peptide sequenced (pmol), R is the repetitive yield, and f(x) is the picomoles detected in cycle x. Ser, His, Trp, and Cys were not included in the fits due to known problems with their accurate detection/quantification. The fit was calculated in SigmaPlot 2001 (SPSS) using a nonlinear least-squares method, and figures containing 125 I release profiles include this fit as a dotted line. Some sequencing samples were treated with OPA prior to a cycle known to contain a proline (21) . OPA reacts with all N-terminal amino acids (but not with the imino acid proline) and blocks further Edman degradation (22) . Thus, release of 125 I in a cycle after an OPA treatment establishes that the 125 I release originates from a peptide with a proline in the OPA-treated cycle. Quantification of 125 I incorporated into a specific residue was calculated by (cpm x -cpm (x-1) )/5I o R x , and then the value was decay corrected to the date of labeling.
Molecular Modeling. A homology model of the human R4 2 nAChR was built on the Torpedo marmorata nAChR structure (PDB code 2BG9) using the homology module within the Insight II molecular modeling package (Accelrys). Two R4 sequences were aligned with and substituted into the two R1 subunits in the model, and 2 sequences were aligned with and substituted into each of the remaining subunits ( 1, γ, and δ) to create a receptor with a stochiometry of 2R4:3 2.
RESULTS
Affinity Purification of R4 2 nAChR.
In the absence of a natural rich source of R4 2 nAChRs, one alternative is a cell line that stably expresses R4 2 nAChRs. HEK-293 cells stably or transiently transfected with R4 2 nAChRs express functional receptors and have been used by several groups as an in vitro system to study structural and functional aspects of the neuronal nAChR including the pharmacology of ligand binding (13, (23) (24) (25) , agonist-induced upregulation (10, 26) , subunit stoichiometry (27) , and the effect of steroids (28, 29) .
The expression level of hR4 2 nAChRs in HEK-hR4 2 is typically ∼5 pmol of receptor/mg of protein with a [ 3 H]-nicotine binding affinity (K d ) of ∼6 nM (data not shown), consistent with the equilibrium binding affinity for nicotine measured using cell homogenates expressing rat or human R4 2 nAChRs (30). Treatment of HEK-R4 2 cells with 100 µM nicotine 24 h prior to harvesting enhanced the level of hR4 2 nAChR expression by 3-fold (∼15 pmol of receptor/mg of protein, data not shown).
When receptor solubilization in various detergents including CHAPS, sodium cholate, and Triton X100 was tested, we found similar levels of solubilization (40-60% of the total protein), with no preferential nAChR solubilization. We decided to use cholate for solubilization because (i) it can be readily removed by dialysis following purification, allowing reconstitution of the receptor into a lipid environment, and (ii) Torpedo nAChRs solubilized in cholate are stabilized in the resting (closed) state and retain the ability to undergo agonist-induced conformational transitions (31 Human R4 2 nAChRs were affinity-purified using a bromoacetylcholine bromide-derivatized Affi-Gel 10 column (see the Experimental Procedures). This ACh-affinity column has been used to purify Torpedo nAChRs (32, 15) , but its application to the purification of neuronal nAChRs has been very limited (33, 34) . A number of factors, including the low abundance of neuronal nAChRs in native tissues (<1 pmol/mg) as well as the heterogeneity of nAChR subtypes, have all contributed to the scarcity of reports involving neuronal nAChR purification. For each column purification, HEK-R4 2 membranes from ∼1000 culture dishes (20 × 140 mm) were collected over a six-week period and solubilized in 1% cholate in VDB. The solubilized material was dialyzed for 5 h against 1% cholate in VDB and applied slowly to the affinity column. The dialysis step was a critical aspect of the purification strategy; in its absence nAChRs were not retained on the ACh-affinity column. The column was then washed extensively with a defined lipid/1% cholate solution, and bound nAChRs were then eluted from the column using the same solution containing 10 mM carbamylcholine. Fractions were collected, the protein concentration was determined (see Supporting Information Figure 1) , and the peak protein fractions were pooled and dialyzed against VDB to remove carbamylcholine and detergent (reconstitution). For a typical column run (for HEK cells grown in the absence of nicotine), we started with ∼3 g of HEK-hR4 2 membrane protein containing ∼10 nmol of nicotine binding sites (∼4 mg of R4 2 nAChR protein), and the yield following detergent solubilization and affinity purification was ∼50% (2.2 mg of receptor at ∼4 nmol of [ 3 H]nicotine binding sites/mg of protein).
When an aliquot (∼50 µg) of affinity-purified R4 2 nAChRs was resolved on a 1 mm thick 8% polyacrylamide gel, two primary Coomassie Blue-stained bands were visible with apparent molecular masses of 70 and 48 kDa ( Figure  1A) . The 70 and 48 kDa bands correspond to the expected electrophoretic mobility of the R4 and 2 nAChR subunits, respectively (35) . This conclusion was confirmed by Nterminal sequencing and by LC/MS (Taplin Biological Mass Spectrometry Facility, Boston, MA). On the basis of densitometric scans of the Coomassie Blue-stained gel (Supporting Information Figure 2A ) and saturation [ 3 H]nicotine binding (∼4 nmol/mg of protein), we estimated that the R4 2 nAChR preparation was greater than 50% pure. The relative intensities of the R4 and 2 subunit bands in the stained 8% gel (Supporting Information Figure 2A ) were consistent with a subunit stoichiometry of (R4) 2 ( 2) 3 (36) . Both the percent yield and the purity based on SDS-PAGE were reproducible in three successive purifications starting with ∼1000 culture dishes.
[ 125 I]TID Photolabeling of the R4 2 nAChR. The hydrophobic photoreactive probe [ 125 I]TID was used to study the structure of the lipid-protein interface of the R4 2 nAChR and to identify individual amino acid residues in the R4 and 2 subunits that are in contact with membrane lipid. [
125 I]-TID is a small hydrophobic photoreactive compound that partitions efficiently (>95%) into the lipid bilayer and upon activation with UV light (365 nm) covalently tags amino acid residues that are in contact with the lipid bilayer (12) . Purified R4 2 nAChRs were equilibrated for 1 h with [ 125 I]-TID in the absence or presence of 400 µM Carb and irradiated at 365 nm for 7 min, and then the polypeptides were resolved by SDS-PAGE. After electrophoresis, the gel was stained, destained, dried, and exposed to X-ray film. As shown in Figure 1B To generate subunit fragments containing incorporated [ 125 I]TID, the R4 and 2 subunit bands were excised from the stained 8% polyacrylamide gel, transferred to the wells of 15% acrylamide mapping gels, and subjected to in-gel digestion with S. aureus V8 protease as described in the Experimental Procedures. On the basis of autoradiography of the dried mapping gel (Figure 2A , with an N-terminus just 11 amino acids before the beginning of M4, was isolated from a preparative labeling (1 mg of affinity-purified hR4 2) and purified by reversed-phase HPLC ( Figure 3A) . The [ 125 I]-TID-labeled fragments, 2V8-13 and R4V8-14, with Ntermini 64 and 99 amino acids, respectively, before the beginning of M4, were digested with trypsin, and the digests were fractionated by reversed-phase HPLC ( Figure 3B,C) . Peak 125 I HPLC fractions were pooled, loaded onto PVDF supports, and sequenced.
When HPLC-purified 2V8-8 was sequenced ( Figure 3D ), a single amino acid sequence was detected beginning at 2-Asp 425 (10 pmol). There was a peak of Figure 1B) were transferred to the well of a 15% acrylamide mapping gel and subjected to in-gel digestion with V8 protease. Following electrophoresis, the mapping gel was stained, destained, dried, and exposed to an X-ray film with an intensifying screen. (Figure 5A ) of the dried Tricine gel revealed a primary radioactive band migrating with an apparent molecular mass of 12 kDa ( 2T12K), as well as secondary bands of 10 kDa ( 2T10K) and 6 kDa ( 2T6K). When the labeled bands were recovered from the gel and purified by reversed-phase HPLC, 125 I was recovered in broad hydrophobic peaks, as seen in Figure 5B for 2T12K. N-terminal sequence analysis for 2T12K and 2T10K established that each band contained a fragment beginning at 2-Lys 208 , the N-terminal of 2M1. Since the labeled fragment began at 2-Lys 208 , the peak of 125 I from the HPLC purification of 2T12K was sequenced with OPA treatment prior to cycle 2, corresponding to 2-Pro 209 . The amino acid sequence of the peptide beginning at 2-Lys 208 (1 pmol, Figure 5C ) continued after treatment with OPA, and there was 125 I release in cycle 13 (90 cpm) corresponding to labeling of 2-Cys 220 (70 cpm/pmol).
DISCUSSION
The crucial role of neuronal nAChRs in several neuronal diseases makes them an important drug target. Development of agonist, antagonist, and allosteric modulators of R4 2 nAChRs provides a potential hope for a better understanding of and improved treatment for pathophysiological conditions that include Alzheimer's disease and nicotine addiction (37, 38) . Among other factors, a more refined understanding of the molecular structure of the R4 2 nAChR is a prerequisite for the development of such ligands. In this study, we sought to obtain large quantities of highly purified human R4 2 nAChRs and to begin direct structural studies of the purified receptor. Starting with membrane preparations from an HEKhR4 2 stable cell line, we were able to purify R4 2 nAChRs using an acetylcholine-derivatized affinity column. The yields (2-3 mg) and levels of purity (>50%), which were reproduced in three different purifications, are sufficient to apply a variety of structural techniques, including photoaffinity labeling, to characterize the structure of the R4 2 nAChR. Our purification results have several advantages compared with those of previous purifications of neuronal nAChRs from rat brain using monoclonal antibody affinity chromatography (39) or an acetylcholine affinity column alone (33) reported high levels of receptor enrichment (e.g., 13000-fold enrichment (34) and 7000-13000-fold enrichment (33)), the specific activity of the purified receptor was at best 0.4 nmol of [ 3 H]ACh binding site/mg of protein, and the reported protein yields were either at the microgram level (20 µg; 34) or below the level of detection (33) . Furthermore, the yields from rat brain were low and variable (4-20%), suggesting that different populations of neuronal nAChR subtypes were purified depending on the type of column used (33) . (iii) The use of acetylcholine-derivatized affinity chromatography in a single-step purification minimizes the time of the purification procedure and, most importantly, minimizes the time in which the receptor is complexed with detergent; (iv) In the present study, the receptor was solubilized using 1% cholate, a relatively mild detergent, which has been shown to retain the resting state conformation of the Torpedo nAChR (31), and can be removed efficiently by dialysis for reconstitution of the purified receptor into lipid (bilayer containing) vesicles. This one-step purification and lipid-reconstitution protocol increases the likelihood that the purified receptor will retain its native three-dimensional structure in a membrane environment that is supportive of functionality (i.e., agonist-induced conformational transitions).
To begin structural characterization of purified R4 2 nAChRs, we employed [ 125 I]TID as a probe of the receptor lipid-protein interface. [ 125 I]TID is a small hydrophobic photoreactive compound that has been used extensively to study the structure of Torpedo nAChRs (11, 12, (40) (41) (42) . When affinity-purified and lipid-reconstituted R4 2 nAChRs were labeled with [ 125 I]TID, both R4 and 2 subunits incorporated equal amounts of the probe. The R4: 2 labeling ratio (0.6, Supporting Information Figure 2B ) was reflective of the relative amounts of R4 versus 2 subunit (2R4:3 2, Supporting Information Figure 2B ) that other approaches have shown likely represent the predominant subunit stoichiometry (36) . Identical results were obtained for R4 2 nAChRs purified from HEK-R4 2 cells that had been exposed to 100 µM nicotine 24 h prior to harvesting, indicating that nicotine exposure did not significantly alter the subunit stoichiometry for this stably transfected HEK cell line (but see ref 27) .
Unlike [ 125 I]TID labeling was mapped to amino acids in the M4 and M1 segments of both the R4 and 2 subunits. For both R4 and 2 subunits ∼60% of the total labeling was localized within fragments that contain the M4 segment, which suggests that the M4 helix has the greatest exposure to lipid, consistent with the published structure of the Torpedo nAChR (7) . Amino acid sequence analysis of the [ 125 I]TIDlabeled subunit fragment 2V8-8 and the 125 I HPLC peaks from the tryptic digests of 2V8-13 and R4V8-14 revealed labeling within 2M4 and R4M4 of the homologous amino acids 2-Cys 445 and R4-Cys 582 ( Figure 4D , cycle 21; Figure  4E , cycles 18 and 31; Figure 4F , cycle 18). Amino acid sequence alignment of the M4 segments of human R4, human 2, and Torpedo R1 nAChR subunits ( Figure 6C ) shows that the labeled residues 2-Cys 445 and R4-Cys ) are all located at the lipid-protein interface of the R4 2 nAChR and are situated near the middle of the lipid bilayer. These results provide the first experimental evidence that supports the existence of a high degree of structural homology between the lipid-protein interfaces of the neuronal R4 2 nAChR and the Torpedo nAChR.
The predominant incorporation of [ 125 I]TID into cysteine residues undoubtedly reflects the high intrinsic reactivity of the cysteine side chain compared to the side chains of other amino acids (43) . [ 125 I]TID labeled each of the cysteines in the M4 segments of the Torpedo nAChR R1, 1, and γ subunits, while in δM4, which lacks cysteines, δSer457 was labeled (12 (12) . Collectively these results support the conclusion that the position of the amino acid, that is, the degree of exposure to lipid, is the primary determinant of labeling by [ 125 I]TID, with side chain reactivity then providing a secondary factor. The combination of these two factors then determines the overall labeling pattern.
To identify potential sites of [ 125 I]TID labeling in the M3 and/or M2 segments of R4 and 2 subunits, [ 125 I]TID-labeled R4V8-16 ( Figure 2A ) and 2V8-21 ( Figure 2B ) fragments were exhaustively digested with trypsin (>1:1 (w/w) ratio of protease to substrate). When the tryptic digest of R4V8-16 was fractionated by Tricine SDS-PAGE, two labeled bands with apparent molecular masses of 10 kDa (R4T10K) and 6 kDa (R4T6K) were evident (data not shown). While the N-terminal sequencing of HPLC-purified R4T6K gave no clear sequence, N-terminal sequencing of the HPLCpurified R4T10K revealed a peptide beginning at R4-Leu 214 , one residue before the N-terminus of the R4M1 segment. Digestion of 2V8-21 with trypsin ( Figure 5 ) did not result in the isolation of either the M2 or M3 segment. We conclude from these results that site(s) for tryptic cleavage that are present at the N-terminus of M2 and M3 are very resistant to proteolysis. Additional work, including the use of alternative proteases, will be necessary to determine whether [ 125 I]-TID photolabels amino acids in the M3 and/or M2 segments. 
SUPPORTING INFORMATION AVAILABLE
A typical elution profile of the hR4 2 neuronal nAChR from an acetylcholine-derivatized affinity column (Figure 1 ), densiometric analysis of Coomassie Blue R-250-stained gel (Figure 2A) , and quantification of [ 125 I]TID incorporation into R4 and 2 nAChR subunits ( Figure 2B ). This material is available free of charge via the Internet at http:// pubs.acs.org.
